Mark Needles

Statistics

Publications

Citations

H-Index

Active since

2023

Affiliations

United States Food and Drug Administration(Current)

University of California, San Francisco

Orthopaedic Research of Virginia

George Washington University

Duke Medical Center

Mark Needles is an author at United States Food and Drug Administration specializing in outcome ranking, clinical trials, and clinical trial efficacy endpoints.

Publications per year

2023–2023

Publications

Exploration of a Potential Desirability of Outcome Ranking Endpoint for Complicated Intra-Abdominal Infections Using 9 Registrational Trials for Antibacterial Drugs

Tori Kinamon, Ramya Gopinath, Ursula Waack et al. · Clinical Infectious Diseases · 2023 · 22 citations · Full text

Pharmacy, Pharmacotherapy, Antimicrobial Pharmacotherapy +14

Moving Beyond Mortality: Development and Application of a Desirability of Outcome Ranking (DOOR) Endpoint for Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia

Jessica Howard‐Anderson, Toshimitsu Hamasaki, Weixiao Dai et al. · Clinical Infectious Diseases · 2023 · 18 citations · Full text

Pharmacy, Infectious Diseases, Pharmacology +15

1–2 of 2